
About this episode
The safety of very low LDL-C, the win-ratio analytic method, sacubitril/valsartan, SGLT2 inhibitors, and percutaneous left atrial appendage closure are discussed in this week's podcast.
This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I PCSK9I
Evolocumab Benefits Accrue With Longer Follow-up: FOURIER OLE
https://www.medscape.com/viewarticle/979950
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
https://www.nejm.org/doi/full/10.1056/nejmoa1615664
- Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.061620
II Analytic Methods and Re-Analysis of Old Trials
- PARADISE-MI Results Obscured As Post Hoc Analysis Finds Flaws
https://www.medscape.com/viewarticle/980776
- Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction
https://www.nejm.org/doi/10.1056/NEJMoa2104508
- Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057429
- The Year's Most Important Study Adds to Uncertainty in Science
https://www.medscape.com/viewarticle/904286
III SGLT2i Post MI
- Early Signal of Benefit for Empagliflozin in Acute MI: EMMY
https://www.medscape.com/viewarticle/980180
- Empagliflozin in acute myocardial infarction: the EMMY trial
https://doi.org/10.1093/eurheartj/ehac494
IV Percutaneous Left Atrial Appendage Closure
- Incidence and Predictors of Early Death in Patients Undergoing Percutaneous Left Atrial Appendage Closure
https://www.jacc.org/doi/10.1016/j.jacep.2022.06.012
- Cost‐Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5‐Year, Long‐Term Data
https://www.ahajournals.org/doi/10.1161/JAHA.118.011577
- Baseline Comorbidities And Bleeding Events Of Patients Undergoing Percutaneous Left Atrial Appendage Occlusion Among Medicare Beneficiaries
https://www.jacc.org/doi/10.1016/S0735-1097%2822%2901158-5
You may also like:
Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
https://www.medscape.com/features/public/machine
The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.
https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
Get every episode summarized
Each time This Week in Cardiology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Cardiology

Sep 11 2026 This Week in Cardiology
This Week in Cardiology

Sep 04 2026 This Week in Cardiology
This Week in Cardiology

Aug 28 2026 This Week in Cardiology
This Week in Cardiology

August 21 2026 This Week in Cardiology
This Week in Cardiology